Biochemical Nature and Cellular Distribution of the Paired Immunoglobulin-like Receptors, PIR-A and PIR-B
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
PIR-A and PIR-B, paired immunoglobulin-like receptors encoded, respectively, by multiple Pira genes and a single Pirb gene in mice, are relatives of the human natural killer (NK) and Fc receptors. Monoclonal and polyclonal antibodies produced against a recombinant PIR protein identified cell surface glycoproteins of ∼85 and ∼120 kD on B cells, granulocytes, and macrophages. A disulfide-linked homodimer associated with the cell surface PIR molecules was identified as the Fc receptor common γ (FcRγc) chain. Whereas PIR-B fibroblast transfectants expressed cell surface molecules of ∼120 kD, PIR-A transfectants expressed the ∼85-kD molecules exclusively intracellularly; PIR-A and FcRγc cotransfectants expressed the PIR-A/ FcRγc complex on their cell surface. Correspondingly, PIR-B was normally expressed on the cell surface of splenocytes from FcRγc−/− mice whereas PIR-A was not. Cell surface levels of PIR molecules on myeloid and B lineage cells increased with cellular differentiation and activation. Dendritic cells, monocytes/macrophages, and mast cells expressed the PIR molecules in varying levels, but T cells and NK cells did not. These experiments define the coordinate cellular expression of PIR-B, an inhibitory receptor, and PIR-A, an activating receptor; demonstrate the requirement of FcRγc chain association for cell surface PIR-A expression; and suggest that the level of FcRγc chain expression could differentially affect the PIR-A/PIR-B equilibrium in different cell lineages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells
Kubagawa, H., Burrows, P. D., & Cooper, M. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5261 · Cited by 319
Self-citation
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Self-citationRavetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
Self-citationBouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284
B cell antigen receptor signaling 101
DALPORTO, J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.008 · Cited by 537
B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation
Prasad, D. V. R., Richards, S., Mai, X. M., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00147-x · Cited by 431
Negative signaling by inhibitory receptors: the NK cell paradigm
Long, E. O. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00660.x · Cited by 370
Murine B7-H3 is a negative regulator of T cells
Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2500 · Cited by 368
Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Inhibitory Pathways Triggered by ITIM-Containing Receptors
Bolland, S., & Ravetch, J. V. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60019-x · Cited by 220
Self-citationMa, G., Pan, P.-Y., Eisenstein, S., Divino, C. M., Lowell, C. A., Takai, T., & Chen, S.-H. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.004 · Cited by 174
“Data shown are from representative of six reproducible experiments. macrophages, neutrophils, mast cells, and B cells (Kubagawa et al., 1999).”
InfluentialImpaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice
Ujike, A., Takeda, K., Nakamura, A., Ebihara, S., Akiyama, K., & Takai, T. (2002) · Nature Immunology · doi:10.1038/ni801 · Cited by 170
“2), anti–mouse IgD (11-26), anti–mouse CD3 (145-2C11), anti–mouse CD5 (Ly-1), anti–mouse B220 (RA3-6B2), anti–mouse CD21 (7G6), anti–mouse CD23 (B3B4), anti–ckit (2B8), anti-CD11b (M1/70), anti-CD11c (HL3), anti-CD80 (16-10A1), anti-CD86 (GL1), CD40 (3/23), anti–MHC class II (M5/114.”
InfluentialPaired immunoglobulin‐like receptors and their MHC class I recognition
Takai, T. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02177.x · Cited by 167
Human leukocyte immunoglobulin-like receptors in health and disease
Redondo-García, S., Barritt, C., Papagregoriou, C., Yeboah, M., Frendeus, B., Cragg, M. S., & Roghanian, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1282874 · Cited by 53
Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells
Dietrich, J., Nakajima, H., & Colonna, M. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00294-x · Cited by 53
Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Deng, M., Chen, H., Liu, X., Huang, R., He, Y., Yoo, B., Xie, J., John, S., Zhang, N., An, Z., et al. (2021) · Antibody Therapeutics · doi:10.1093/abt/tbab002 · Cited by 53
Role of PIR‐B in Autoimmune Glomerulonephritis
Takai, T., Nakamura, A., & Endo, S. (2011) · BioMed Research International · doi:10.1155/2011/275302 · Cited by 32
Metadata
- Authors
- Kubagawa, H., Chen, C.-C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C., Uehara, T., Ravetch, J. V., & Cooper, M. D.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-01-18
- Volume
- 189
- Issue
- 2
- Pages
- 309-318
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2145651936
- Cited by
- 148
- References
- 2
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.